In letters to the Centers for Medicare & Medicaid Services (CMS), ASCO President Bruce E. Johnson, MD, FASCO, comments on provisions in the proposed rules for the 2018 Medicare Physician Fee Schedule (MPFS) and the 2018 Hospital Outpatient Prospective Payment System (HOPPS) that will affect the delivery of oncology care in multiple settings.
ASCO in Action regularly provides the latest news and analysis related to cancer policy news; see the following online articles. These updates provide snapshots of ASCO’s ongoing advocacy efforts, as well as opportunities for ASCO members and guests to take action on critical issues affecting the cancer community.
To sign up for advocacy alerts, log in to ASCO.org with your ASCO member or guest account, and visit the subscription center available under your account profile.
ASCO recently submitted comments to the House Ways and Means Health Subcommittee regarding its “Medicare Red Tape Relief Project, which aims to alleviate the regulations and mandates in the Medicare program that impede innovation, increase costs, and prevent the delivery of better care to beneficiaries.
Oncology practices across the country are currently implementing the Quality Payment Program. In 2017, practices have minimal reporting requirements in order to avoid financial penalties in 2019, but ASCO encourages practices to report on at least four measures to become fully acquainted with the system and to ensure that CMS requirements are met. Practices that can report a bit more data may also try to earn a small positive payment adjustment in 2019. Is your practice thinking about trying to earn a small positive payment adjustment? Here are the top five things you need to know.
Did you miss any of ASCO’s webinar series on successful data reporting under the Quality Payment Program (QPP)? Would you like a refresher now that 2017 deadlines are approaching? If so, the entire webinar series is now available online to guide oncology practices to successful 2017 reporting under QPP and the Merit-Based Incentive Payment System.
In a statement submitted to a House Energy and Commerce health subcommittee hearing entitled, “Examining Bipartisan Legislation to Improve the Medicare Program,” ASCO expressed strong support for two pieces of legislation that aim to strengthen Medicare.
The next installment of ASCO’s webinar series on the Quality Payment Program (QPP) will take place Monday, July 10 at 4:00 p.m. ET. The webinar, entitled Quality Payment Program: Optimizing your MIPS Score, will help participants optimize their Merit-Based Incentive Payment System (MIPS) score in order to receive the full reimbursement they are entitled to for services provided under Medicare Part B.
The Centers for Medicare & Medicaid Services released its proposed rule outlining changes to the Quality Payment Program (QPP) for 2018. The proposal became available on June 20 and is scheduled to be published in the Federal Register on June 30.
The next installment of ASCO’s webinar series on the Quality Payment Program (QPP) will take place Monday, June 19 at 4:00 p.m. ET. The webinar, entitled Quality Payment Program: Scoring for Advancing Care Information and Improvement Activities, will help participants understand QPP’s Advancing Care Information and Improvement Activities Attestation measures. These measures make up two of the four categories that determine a Merit-Based Incentive Payment System (MIPS) score, and ultimately participants’ Medicare Part B reimbursement.
ASCO joined nearly 270 patient and provider advocacy groups in signing a letter (LINK) to U.S. Department of Health and Human Services (HHS) Secretary Tom Price, urging the agency to formally withdraw the Obama Administration’s proposed Medicare Part B Drug Payment Model.
ASCO has developed a “MACRA decision tree” tool to help oncology practices find precise information on their QPP participation status, and any applicable Merit-Based Incentive Payment System (MIPS) exceptions, based on practice or provider-specific information.
ASCO has joined a coalition of more than a dozen specialty societies in supporting an effort in the U.S. House of Representatives to relieve the significant administrative burdens and financial penalties slated to be imposed on physicians in 2018 as part of the Medicare physician fee schedule (MPFS)—due to be released this summer. ASCO is concerned about the impact these burdens could have on patient care since oncologists would have to juggle the requirements of multiple Medicare quality improvement programs in addition to time spent providing patient care.
ASCO recently submitted comments to the Centers for Medicare & Medicaid Services (CMS) in response to the agency’s call for stakeholder input on measuring and comparing oncologists and other health care providers based on cost under the Quality Payment Program’s (QPP) Merit-Based Incentive Payment System (MIPS).
This year, oncology practices across the country are implementing changes to comply with the Quality Payment Program (QPP), established by the Medicare Access and CHIP Reauthorization Act (MACRA), which will transition practices from the current fee-for-service reimbursement system to providing value-based cancer care.
ASCO recently joined more than 180 patient and provider advocacy groups in signing a letter to the Medicare Payment Advisory Commission (MedPAC), urging the congressional advisory group to reconsider proposed changes to Medicare Part B drug reimbursement.